Episiotomy..
Conditions
Interventions
Intervention 1: Intervention group: Women who are experiencing their first childbirth and are scheduled to receive topical calcipotriol cream. Intervention 2: Control group: Women who are experiencing
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: primiparous women who have undergone an episiotomy Vaginal delivery with a mediolateral episiotomy Having provided written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: Participants with underlying medical conditions such as diabetes, dermatologic diseases, immunodeficiency, or autoimmune disorders were excluded from the study. Women who reported taking supplements or medications containing vitamin D or similar topical creams in the past two weeks. The use of topical or oral medications with potential effects on wound healing. Participants with a known allergy to creams or ointments containing vitamin D. Unwillingness to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Episiotomy wound healing based on REEDA criteria. Timepoint: Days 3-5-10. Method of measurement: Based on the characteristics of redness, inflammation, wound distance, and discharge.;Episiotomy pain based on visual pain diagnosis. Timepoint: Day 3,5,10. Method of measurement: Based on visual analogue scale.;Women's satisfaction with wound healing and pain reduction. Timepoint: days 3-5-10. Method of measurement: Based on the researcher-made satisfaction form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGhazal
Ahvaz University of Medical Sciences
Outcome results
None listed